Medical R&D Tax Credits
Within the medical sector, there is a continuous need for research and development (R&D). Whether it is for next generation medical devices, technologies and products, new and improved pharmaceuticals, or research into the use of genomics, AI or smart packaging; it is all R&D!
There is a large amount of funding available to the medical sector for R&D, but did you know that medical companies can also claim R&D tax credits for the work they are doing? They can even claim R&D tax relief if the company is loss making, if the project was unsuccessful and if the R&D was grant funded!
All of the above are examples of activities in the medical sector that are eligible for an R&D tax claim. As long as the R&D being done is to overcome a technical or scientific uncertainty, then it could be eligible!
Our Consultant’s are experts at delving deep into your R&D projects and identifying all of the eligible activity within them; making sure your claim is maximised to it’s fullest potential.
These statistics are based on 215 claims within the health sector in the financial year. Only 20% of the average expenditure is being claimed back, which we believe is far below what it should be!
Still not sure?
An R&D tax credit claim could be the cash injection needed to fund the next steps of the development journey! Use our R&D Tax Credit Calculator today to see how much you could potentially claim back!
Get in touch and our R&D Tax Credit Consultants can decipher from a FREE quick telephone consultation, whether the activities being undertaken are eligible and let you know exactly which project costs can be claimed back on.
A detailed summary of the First-tier Tribunal’s decision in Realbuzz Group Ltd v HMRC (May 2025), focusing on the limits of HMRC’s discovery assessment powers in relation to R&D tax relief claims. We touch on key tribunal issues including the “hypothetical officer” test, the importance of adequate disclosure, and the legal protections available to taxpayers. The ruling offers important guidance for companies claiming R&D tax credits and clarifies HMRC’s ability to revisit prior-year claims.
The May 2025 Research & Development Communication Forum (RDCF) returned to an in-person format for the first time since the pandemic. Held in a historic setting with a focus on open dialogue, the forum covered key updates from HMRC, including policy changes, operational performance, and ongoing efforts to improve the R&D claims process. In this article, we share updates from the RDCF and our reflections on what it all means for businesses and advisors moving forward.
Assists organisations in accessing research and development grant funding across a range of UK and EU schemes and industry sectors.
Get In Touch
Call 
Back
